<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>CardioBrief</title>
	<atom:link href="http://cardiobrief.org/feed/" rel="self" type="application/rss+xml" />
	<link>http://cardiobrief.org</link>
	<description>One-stop source for cardiology news and links</description>
	<lastBuildDate>Sat, 04 Feb 2012 01:14:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='cardiobrief.org' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://1.gravatar.com/blavatar/5706effc1b2c62d7b9c46c6c74eb5d86?s=96&#038;d=http%3A%2F%2Fs2.wp.com%2Fi%2Fbuttonw-com.png</url>
		<title>CardioBrief</title>
		<link>http://cardiobrief.org</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://cardiobrief.org/osd.xml" title="CardioBrief" />
	<atom:link rel='hub' href='http://cardiobrief.org/?pushpress=hub'/>
		<item>
		<title>CMS Releases Details Of Proposed National Coverage For TAVR</title>
		<link>http://cardiobrief.org/2012/02/02/cms-releases-details-of-proposed-national-coverage-for-tavr/</link>
		<comments>http://cardiobrief.org/2012/02/02/cms-releases-details-of-proposed-national-coverage-for-tavr/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 02:38:23 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Interventional Cardiology & Surgery]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[medicare coverage]]></category>
		<category><![CDATA[National Coverage Determination]]></category>
		<category><![CDATA[TAVI]]></category>
		<category><![CDATA[TAVR]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10731</guid>
		<description><![CDATA[(Updated with statement from the ACC and STS) On Thursday the Centers for Medicare &#38; Medicaid Services (CMS) released a memo containing details of its proposed Medicare coverage for TAVR (transcatheter aortic valve replacement). The memo is a response to a formal request for national coverage determination (NCD) from the Society of Thoracic Surgeons (STS) and [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10731&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/02/02/cms-releases-details-of-proposed-national-coverage-for-tavr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Study Explores Role of Periprocedural Dabigatran in AF Ablation</title>
		<link>http://cardiobrief.org/2012/02/02/study-explores-role-of-periprocedural-dabigatran-in-af-ablation/</link>
		<comments>http://cardiobrief.org/2012/02/02/study-explores-role-of-periprocedural-dabigatran-in-af-ablation/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 20:24:59 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Heart Rhythms]]></category>
		<category><![CDATA[ablation]]></category>
		<category><![CDATA[AF]]></category>
		<category><![CDATA[AF ablation]]></category>
		<category><![CDATA[anticoagulation]]></category>
		<category><![CDATA[dabigatran]]></category>
		<category><![CDATA[oral anticoagulants]]></category>
		<category><![CDATA[Pradaxa]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10722</guid>
		<description><![CDATA[Updated with a comment from John Mandrola&#8211; As dabigatran becomes more widely used in atrial fibrillation (AF) patients, electrophysiologists are now trying to figure out how to handle anticoagulation in patients taking dabigatran (Pradaxa) for whom AF ablation is planned. In a new study published in the Journal of the American College of Cardiology, Dhanunjaya Lakkireddy and colleagues [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10722&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/02/02/study-explores-role-of-periprocedural-dabigatran-in-af-ablation/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Meta-Analysis Confirms Benefits Of Statins In Women</title>
		<link>http://cardiobrief.org/2012/02/01/meta-analysis-confirms-benefits-of-statins-in-women/</link>
		<comments>http://cardiobrief.org/2012/02/01/meta-analysis-confirms-benefits-of-statins-in-women/#comments</comments>
		<pubDate>Wed, 01 Feb 2012 17:55:03 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[journal of the american college of cardiology]]></category>
		<category><![CDATA[lori mosca]]></category>
		<category><![CDATA[prevention trials]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10709</guid>
		<description><![CDATA[Although clinical trials have consistently found a beneficial effects for statins, some critics have questioned the strength of the evidence in women, who are often under-represented in clinical trials.  A large new meta-analysis published in the Journal of the American College of Cardiology provides the best evidence yet that the relative reductions in events observed in [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10709&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/02/01/meta-analysis-confirms-benefits-of-statins-in-women/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Consensus Document Provides Roadmap To Uptake Of TAVI In US</title>
		<link>http://cardiobrief.org/2012/01/31/consensus-document-provides-roadmap-to-uptake-of-tavi-in-us/</link>
		<comments>http://cardiobrief.org/2012/01/31/consensus-document-provides-roadmap-to-uptake-of-tavi-in-us/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 19:00:12 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Interventional Cardiology & Surgery]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[aortic stenosis]]></category>
		<category><![CDATA[aortic valve replacement]]></category>
		<category><![CDATA[TAVI]]></category>
		<category><![CDATA[TAVR]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10699</guid>
		<description><![CDATA[Following the recent approval by the FDA of transcatheter aortic valve replacement (TAVR), the ACC, AATS, SCAI, and STS, in conjunction with several other medical organizations, have released a critical consensus document to guide use of the new landmark procedure. “We have tried to collate the evidence into a coherent road map for judicious use, rational [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10699&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/31/consensus-document-provides-roadmap-to-uptake-of-tavi-in-us/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Robert Harrington Leaving Duke for Stanford University</title>
		<link>http://cardiobrief.org/2012/01/30/robert-harrington-leaving-duke-for-stanford-university/</link>
		<comments>http://cardiobrief.org/2012/01/30/robert-harrington-leaving-duke-for-stanford-university/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 22:17:18 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[People, Places & Events]]></category>
		<category><![CDATA[DCRI]]></category>
		<category><![CDATA[Duke]]></category>
		<category><![CDATA[Harrington]]></category>
		<category><![CDATA[Stanford]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10692</guid>
		<description><![CDATA[Robert Harrington will be leaving his position as the director of the Duke Clinical Research Institute, a position he has held since 2006, to become the new chair of the department of medicine at Stanford University. Harrington was also the Richard S. Stack MD Distinguished Professor at Duke University School of Medicine. The news was publicly [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10692&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/30/robert-harrington-leaving-duke-for-stanford-university/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>

		<media:content url="http://cardiobrief.files.wordpress.com/2012/01/harrington.jpg" medium="image">
			<media:title type="html">Harrington</media:title>
		</media:content>
	</item>
		<item>
		<title>Appropriate Use Criteria for Revascularization Updated</title>
		<link>http://cardiobrief.org/2012/01/30/appropriate-use-criteria-for-revascularization-updated/</link>
		<comments>http://cardiobrief.org/2012/01/30/appropriate-use-criteria-for-revascularization-updated/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 21:10:18 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Interventional Cardiology & Surgery]]></category>
		<category><![CDATA[appropriate use criteria]]></category>
		<category><![CDATA[CABG]]></category>
		<category><![CDATA[cardiac surgeons]]></category>
		<category><![CDATA[left main disease]]></category>
		<category><![CDATA[multivessel disease]]></category>
		<category><![CDATA[PCI]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10688</guid>
		<description><![CDATA[The ACC, AHA, and other organizations have released updated appropriate use criterial for coronary revascularization. The 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update incorporates data from the SYNTAX trial on the indications for PCI and CABG in patients with symptomatic, multivessel disease, as well as data from the CathPCI registry. Here are some of the [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10688&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/30/appropriate-use-criteria-for-revascularization-updated/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Very Large Observational Study Finds Significant Mortality Advantage for CABG Over PCI in High Risk Patients</title>
		<link>http://cardiobrief.org/2012/01/30/very-large-observational-study-finds-significant-mortality-advantage-for-cabg-over-pci-in-high-risk-patients/</link>
		<comments>http://cardiobrief.org/2012/01/30/very-large-observational-study-finds-significant-mortality-advantage-for-cabg-over-pci-in-high-risk-patients/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 19:00:15 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Interventional Cardiology & Surgery]]></category>
		<category><![CDATA[Prevention, Epidemiology & Outcomes]]></category>
		<category><![CDATA[ASCERT]]></category>
		<category><![CDATA[CABG]]></category>
		<category><![CDATA[PCI]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10684</guid>
		<description><![CDATA[Although PCI has a small, early mortality benefit compared to CABG in high risk patients, after the first year a striking survival advantage for CABG develops, according to results of the ASCERT study, presented on Monday at the annual meeting of the Society of Thoracic Surgeons (STS) meeting. Fred Edwards presented the high-risk subset of [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10684&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/30/very-large-observational-study-finds-significant-mortality-advantage-for-cabg-over-pci-in-high-risk-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>ACC 2012 Roster of Late-Breaking Clinical Trials</title>
		<link>http://cardiobrief.org/2012/01/27/acc-2012-roster-of-late-breaking-clinical-trials/</link>
		<comments>http://cardiobrief.org/2012/01/27/acc-2012-roster-of-late-breaking-clinical-trials/#comments</comments>
		<pubDate>Fri, 27 Jan 2012 19:02:17 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10673</guid>
		<description><![CDATA[The American College of Cardiology has released the roster of late-breaking clinical trials that will be presented in March at the ACC Scientific Sessions: ACC.12 Opening Session and Late-Breaking Clinical Trials Saturday, March 24, 2012, 8:00 a.m. – 10:00 a.m. Effect of Transendocardial Autologous Bone Marrow Mononuclear Cell Delivery on Functional Capacity, Left Ventricular Function [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10673&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/27/acc-2012-roster-of-late-breaking-clinical-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Lancet Editor Richard Horton Tweets Dark View of Contemporary Medicine</title>
		<link>http://cardiobrief.org/2012/01/27/lancet-editor-richard-horton-tweets-dark-view-of-contemporary-medicine/</link>
		<comments>http://cardiobrief.org/2012/01/27/lancet-editor-richard-horton-tweets-dark-view-of-contemporary-medicine/#comments</comments>
		<pubDate>Fri, 27 Jan 2012 17:46:28 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[People, Places & Events]]></category>
		<category><![CDATA[Lancet]]></category>
		<category><![CDATA[medical establishment]]></category>
		<category><![CDATA[richard horton]]></category>
		<category><![CDATA[tweets]]></category>
		<category><![CDATA[twitter]]></category>
		<category><![CDATA[world health organization]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10655</guid>
		<description><![CDATA[One brief message at a time, Lancet editor Richard Horton is tweeting his dark view of the contemporary medical establishment. If you have any interest at all in peeking behind the curtain to see what really goes on behind the scenes of top medical organizations then you need to follow Richard Horton&#8217;s Twitter feed. In sudden [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10655&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/27/lancet-editor-richard-horton-tweets-dark-view-of-contemporary-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>

		<media:content url="http://cardiobrief.files.wordpress.com/2012/01/horton.jpg?w=274" medium="image">
			<media:title type="html">Horton</media:title>
		</media:content>
	</item>
		<item>
		<title>NHLBI Launches Two Large Cardiac Arrest Treatment Trials</title>
		<link>http://cardiobrief.org/2012/01/26/nhlbi-launches-two-large-cardiac-arrest-treatment-trials/</link>
		<comments>http://cardiobrief.org/2012/01/26/nhlbi-launches-two-large-cardiac-arrest-treatment-trials/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 17:20:55 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[ems teams]]></category>
		<category><![CDATA[professional cpr]]></category>
		<category><![CDATA[sudden cardiac arrest]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10652</guid>
		<description><![CDATA[The NHLBI today announced the launch of two large clinical trials evaluating treatments for out-of-hospital cardiac arrest. The Continuous Chest Compressions (CCC) trial will randomize 23,600 people with out-of-hospital cardiac arrest to either standard CPR or continuous chest compressions, both delivered by paramedics or fire fighters. In recent years, studies published in the New England Journal of Medicine,  [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10652&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/26/nhlbi-launches-two-large-cardiac-arrest-treatment-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
	</channel>
</rss>
